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Abstract: In our ongoing search for new pharmacologically active leads from Solomon 
organisms, we have examined the sponge Theonella swinhoei. Herein we report the isolation 
and structure elucidation of swinholide A (1) and one new macrolide, swinholide J (2). 
Swinholide J is an  unprecedented asymmetric 44-membered  dilactone with an epoxide 
functionality in half of the molecule. The structural determination was based on extensive 
interpretation  of  high-field  NMR  spectra  and  HRESIMS  data.  Swinholide  J  displayed 
potent  in  vitro  cytotoxicity  against  KB  cells  (human  nasopharynx  cancer)  with  an  
IC50 value of 6 nM. 
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1. Introduction  
Theonella sponges represent an extraordinary source of bioactive secondary metabolites, particularly 
peptides and macrolides. Swinholide A (1) was the first symmetric 44-membered macrolide to be 
isolated from the Red Sea marine sponge Theonella swinhoei [1], and then demonstrated as product of 
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biochemistry  of  symbiontic  microorganisms  [2].  The  structure  was  first  assigned  as  a  monomer, 
revised later to a symmetric cyclic dimer [3], followed by determination of its stereochemistry [4–6]. 
Swinholide A (1) displays impressive biological properties including antifungal activity and potent 
cytotoxicity against a number of tumor cells. Its mechanism of action has been clarified in detail and 
its activity has been attributed to its ability to dimerize actin and disrupt the actin cytoskeleton [7–9]. 
Today, swinholide A is one of the better-characterized membrane permeable and specific inhibitors of 
actin filament networks and is actively used in cell biology studies [10]. 
Several derivatives of swinholide A were reported in the literature. They differ from the parent 
compound in the carbon backbone as in misakinolides [11–13] and hurghadolide [14] which feature a 
40- and 42-membered dilactone structure, respectively, in the regiochemistry of the ring closure as in 
isoswinholide A [15], in the glycosidation, as in ankaraholides A and B [2], in the monomeric structure 
of preswinholide A [16], and in the different symmetric or asymmetric functionalization of the carbon 
backbone as in swinholides B (16′-demethyl) [15], C (29′-O-demethyl) [15], D (15′-O-demethyl) [17], 
E (6′-hydroxy) [17], F (2′-Z conformer) [17], G (20′-demethyl) [17], H (7,7′-O-dimethyl) [18] and 
I (26′-hydroxy) [14]. 
In  our  ongoing  search  for  new  pharmacologically  active  lead  compounds  from  Solomon  
organisms [19–24], we have examined the sponge Theonella swinhoei. Separation of the cytotoxic 
fractions from the CHCl3 extract of a specimen of the marine sponge collected in Vangunu at the 
Solomon Islands, resulted in the identification of swinholide A (1) and of a new potently cytotoxic 
macrolide, swinholide J (2) (Figure 1). 
Figure 1. Swinholides A (1) and J (2) from Theonella swinhoei. 
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2. Results and Discussion  
Swinholide J (2) showed an intense ion peak at m/z 1427.9181 [(M + Na)
+] in the HR ESIMS, 
16 mass  units  higher  than  that  observed  for  1,  corresponding  to  one  additional  oxygen  atom.  
As already reported for several swinholide derivatives [14,15,17], inspection of the 
1H NMR spectrum 
clearly revealed an asymmetric dimeric nature for 2. Notably, the 
1H NMR spectrum of 2 showed 
seven resonances in the region 7.46–5.67 ppm (H-2, H-2′, H-3, H-3′, H-5, H-10/H-10′, H-11/H-11′), 
instead of resonances for five pairs of equivalent protons as in 1 (Table 1). Furthermore, in contrast to 1, 
the 
1H NMR spectrum of swinholide J (2) displayed two additional resonances at ʴH 3.22 [H-5′, dd  
(J = 4.3, 7.4 Hz)] and 1.42 (Me-4′, s). Also, the 
13C NMR spectrum (Table 1), interpreted with the help 
of the HSQC and HMBC experiments, revealed the loss of symmetry in the dilactone skeleton of 2.  
In the 152.4–115.9 ppm region, the 
13C NMR spectrum of 2 showed eight resonances for olefinic 
carbons (nine methines, two of which corresponding to two pairs of equivalent carbons (C-10/C-10′ 
and C-11/C-11′) and one quaternary carbon, C-4), instead of six signals for six pairs of equivalent 
olefinic carbons as seen in 1, and two resonances at ʴC 170.2 and 168.7 for the lactone carbons C-1 and 
C-1′, respectively. Moreover, in the region 55–80 ppm, two additional resonances respect to 1 were 
inferred from analysis of NMR data: one oxygen-bearing methine carbon (ʴC 64.6, ʴH 3.22, C-5′) and 
one oxygen-bearing quaternary carbon (ʴC 59.7, C-4′). 
Table 1. NMR data (700 MHz, CD3OD) for swinholides A (1) and J (2) (ʴ in ppm, J in Hz). 
  1 
a    2 
a 
Position  Type  δH/δH′ (J in Hz)  δC/δC′    δH/δH′ (J in Hz)  δC/δC′  HMBC 
b 
1/1′  C  -  170.6    -  170.2/168.7   
2/2′  CH  5.84 d (15.7)  115.6    5.90 d (15.6)/6.14 d (15.7)  115.9/122.2  C1, C4 
C1′, C4′ 
3/3′  CH  7.43 d (15.7)  152.3    7.46 d (15.6)/6.82 d (15.7)  152.0/152.4  C1, C5 
C1′ 
4/4′  C  -  135.5    -  135.5/59.7   
4/4′-Me  CH3  1.77 s  12.4    1.85 s/1.42 s  12.7/15.5  C3, C4, C5 
C3′, C4′, C5′ 
5/5′  CH  6.14 t (7.3)   140.5    6.16 t (7.2)/3.22 dd (4.3, 7.4)  140.6/64.6  C3, 4-Me 
6/6′  CH2  2.40 t (6.9)  38.8    2.44 m/1.81 m, 1.63 m  38.7/37.9  C4, C5, C7, C8  
7/7′  CH  4.02 m  68.1    3.99 ovl/4.12 m  68.2/66.5   
8/8′  CH2  1.28 m 
1.76 m 
41.0    1.87 m, 1.37 m/ 
1.78 m, 1.37 m 
41.8/41.6   
9/9′  CH  4.47 br d (10.5)  70.5    4.48 br d (10.2)  70.4   
10/10′  CH  5.65 dd (1.8, 10.5)  130.9    5.67 br d (10.3)   130.8   
11/11′  CH  5.81 m  124.9    5.83 m  124.8   
12/12′  CH2  1.94 m  32.2    1.96 m  32.2   
13/13′  CH  3.49 m  65.3    3.54 m  65.4   
14/14′  CH2  1.58 m 
1.77 m 
37.2    1.58 m 
1.82 m 
36.9   
15/15′  CH  3.76 m  78.2    3.76 m/3.83 m  78.4/77.9   
15/15′-OMe  CH3  3.32 s  56.7    3.34 s/3.35 s  56.9/57.2  C15/C15′ Mar. Drugs 2011, 9  
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Table 1. Cont. 
16/16′  CH  1.52 m  43.8    1.55 m  43.3   
16/16′-Me  CH3  0.83 d (6.7)  8.8    0.83 d (7.0)/0.84 d (7.0)   9.2  C15, C16, C17 
C15′, C16′, C17′ 
17/17′  CH  3.61 m  73.2    3.60 m  73.2   
18/18′  CH2  1.63 m 
1.74 m 
39.0    1.61 m 
1.75 m 
39.2   
19/19′  CH  3.97 ovl  70.1    3.97 ovl/3.88 m  70.0/70.1   
20/20′  CH  1.94 m  39.4    1.94 m  39.4   
20/20′-Me  CH3  0.91 d (7.0)  8.9    0.90 d (7.1)/0.91 d (7.1)  9.1   
21/21′  CH  5.46 d (10.5)  75.6    5.45 t (10.3)/5.46 t (10.3)  75.7/76.3   
22/22′  CH  1.98 m  37.9    1.97 m  38.0   
22/22′-Me  CH3  0.94 d (6.9)  9.6    0.92 d (7.0)/0.93 d (7.0)  9.7  C21, C22, C23 
C21′, C22′, C23′ 
23/23′  CH  3.11 dd (1.8, 9.5)  77.2    3.10 m  77.3   
24/24′  CH  1.70 m  34.4    1.70 m  34.5   
24/24′-Me  CH3  0.98 d (6.7)  17.7    0.97 d (6.7)/0.98 d (6.7)  17.9  C23, C24, C25 
C23′, C24′, C25′ 
25/25′  CH2  1.24 m 
1.42 m 
25.1    1.23 m, 1.41 m  25.1   
26/26′  CH2  1.27 m 
1.94 m 
29.7    1.28 m, 1.94 m  29.8   
27/27′  CH  3.99 ovl  72.7    3.98 ovl  72.8   
28/28′  CH2  1.52 m 
1.87 br d (12.8) 
35.8    1.52 m 
1.87 br d (12.5) 
35.8   
29/29′  CH  3.61 m  74.2    3.61 m  74.3  C29-OMe 
C29′-OMe 
29/29′-OMe  CH3  3.34 s  55.3    3.34 s  55.3  C29 
C29′ 
30/30′  CH2  1.09 dd (10.4, 12.6) 
2.01 br d (12.6) 
39.7    1.09 dd (10.4, 12.6) 
2.02 br d (12.6) 
39.7   
31/31′  CH  3.74 m  65.7    3.74 m  65.8   
31/31′-Me  CH3  1.19 d (6.2)  21.8    1.19 d (6.2)  21.8   
a Data from COSY, HSQC, and HMBC experiments; 
b HMBC correlations, optimized for 6 Hz, are from 
proton(s) stated to the indicated carbon. 
All these data clearly suggested a perturbation in the diene moiety of one half of the molecule with 
the introduction of an epoxide functionality. Extensive study of COSY, HSQC, and HMBC spectra 
allowed  us  to  establish  the  presence  in  the  molecule  of  one  half  identical  to  that  of  symmetric 
swinholide  A  (Figure  2).  A  conjugated  double  bond  in  the  other  half  (C-1′–C-3′)  was  inferred 
by COSY correlation between proton signals at ʴH 6.14 (d, J = 15.7 Hz ) and 6.82 (d, J = 15.7 Hz)  
and HMBC cross-peaks H-2′/C-1′ and H-3′/C-1′. The two additional oxygen-bearing carbons were 
placed at C-4′ and C-5′, respectively, on the basis of HMBC correlations from methyl protons at  
ʴH 1.42 (3H, s, Me-4′) to C-3′, C-4′ and C-5′. Definitive confirmation of the proposed structure for Mar. Drugs 2011, 9  
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swinholide  J  (2),  derived  from  2D-HOHAHA  analysis,  showed  correlations  starting  from  H-5′  
(ʴH 3.22) to H-9′ (ʴH 4.48). 
Figure 2. COSY/TOCSY connectivities (bold bonds), HMBC (black arrows) and ROE 
(red arrows) correlations for C-1/C-7 and C-1′/C-7′ partial structures of swinholide J (2). 
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As shown in Table 1, the presence of an epoxy-functionality at C-4′/C-5′ positions at one side of the 
molecule caused twinning of most of the 
1H and 
13C NMR resonances of the nuclei belonging to 
dilactone ring skeleton, without any effect on the signals of the side chain.  
The  large  coupling  constant  (15.7  Hz)  between  two  vinyl  protons  H-2′  and  H-3′  revealed  the  
E-configuration  of  2′-double  bond  whereas  ROE  correlations  Me-4′/H-6′  and  H-5′/H-3′  allowed  
us to established a relative configuration around the epoxide moiety as depicted in Figure 2. The 
stereochemistry of all the remaining stereocenters of swinholide J (2) is suggested to be the same as the 
parent swinholide A (1) on the basis of the similarity in their chemical shift and in the coupling 
constant values. 
Swinholide J (2) was isolated as a very minor component with respect to the parent compound 
swinholide A (1) (relative composition of 1/2 in the sponge extract being 15:1 whereby the % yield 
was calculated based on the wet weight of the CHCl3 extract, swinholide A 0.55% and swinholide J 
0.038%). On this basis, swinholide J (2) could be considered to be artifact arising from the extraction 
and isolation procedures utilized. However, careful HPLC and 
1H NMR (700 MHz) analyses of all 
swinholide-containing  fractions  did  not  show  the  presence  of  other  isomeric  mono-epoxide  or 
diepoxide derivatives that could be obtained through an abiotic radical oxidation of swinholide A (1). 
As such, swinholide J (2) is considered to be a new natural derivative of swinholide A (1) arising from 
a regio- and stereo-selective enzyme mediated oxidation of one of the two dienoate moieties in the 
parent compound.  
Swinholide J (2) showed potent in vitro antiproliferative activity against KB cells, with an IC50 
value of 6.7 nM, comparable to that of the parent compound (IC50 1.2 nM against KB cells) [25]. 
3. Experimental Section 
3.1. General Procedures 
Specific rotations were measured on a Perkin-Elmer 243 B polarimeter. High-resolution ESI-MS 
spectra were performed with a Micromass QTOF Micromass spectrometer. ESI-MS experiments were 
performed on an Applied Biosystem API 2000 triple-quadrupole mass spectrometer. NMR spectra 
were obtained on Varian Inova 700 NMR spectrometer (
1H at 700 MHz, 
13C at 175 MHz, respectively) 
equipped with a Sun hardware, ʴ (ppm), J in Hz, spectra referred to CD3OH as internal standard  
(ʴH 3.31, ʴC 49.0). HPLC was performed using a Waters Model 510 pump equipped with Waters 
Rheodine injector and a differential refractometer, model 401. Mar. Drugs 2011, 9  
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Through-space 
1H connectivities were evidenced using a ROESY experiment with mixing times  
of 200 ms. 
Silica gel (200–400 mesh) from Macherey-Nagel Company was used for flash chromatography. 
3.2. Sponge Material and Separation of Individual Macrolides  
Theonella  swinhoei  (order  Lithistida,  family  Theonellidae)  was  collected  on  the  barrier  reef  of 
Vangunu Island, Solomon Islands, in July 2004. The samples were frozen immediately after collection 
and lyophilized to yield 207 g of dry mass. Taxonomic identification was performed by Dr. John 
Hooper of Queensland Museum, Brisbane, Australia, where specimen is deposited under the accession 
number G3122662. 
The lyophilized material (207 g) was extracted with methanol (3 ×  1.5 L) at room temperature and 
the crude methanolic extract was subjected to a modified Kupchan’s partitioning procedure as follows. 
The methanol extract was dissolved in a mixture of MeOH/H2O containing 10% H2O and partitioned 
against n-hexane (15.2 g). The water content (% v/v) of the MeOH extract was adjusted to 30% and 
partitioned against CHCl3 (5.8 g). The aqueous phase was concentrated to remove MeOH and then 
extracted with n-BuOH (6.0 g). 
The  CHCl3  extract  (5.8  g)  was  chromatographed  by  silica  gel  MPLC  using  a  solvent  gradient 
system from CH2Cl2 to CH2Cl2:MeOH 1:1.  
Fractions eluted with CH2Cl2:MeOH 95:5 (239 mg) were further purified by HPLC on a Nucleodur 
100-5 C18 (5 μm; 7.8 mm i.d. ×  250 mm) with MeOH:H2O (9:1) as eluent (flow rate 1 mL/min) to 
give 2.2 mg of swinholide J (2) (tR = 7.0 min) and 31.7 mg of swinholide A (1) (tR = 7.4 min). 
Biological evaluation. The antiproliferative activity of swinholide A and J was determined on KB 
(nasopharyngeal epidermoid carcinoma) as previously reported [26]. 
3.3. Characteristic Data for Each Compound 
Swinholide  A (1): light yellow solid; [ʱ]D
23 +16.1 (c 0.12, MeOH); 
1H and 
13C NMR data in 
CD3OD given in Table 1; ESIMS: m/z 1411.9 [M + Na]
+. HRMS (ESI): calcd for C78H132NaO20: 
1411.9210; found 1411.9257 [M + Na]
+. 
Swinholide  J  (2):  light  yellow  solid;  [ʱ]D
23  −11.7  (c  0.14,  MeOH); 
1H  and 
13C  NMR  data  in 
CD3OD given in Table 1; ESIMS: m/z 1427.9 [M + Na]
+. HRMS (ESI): calcd for C78H132NaO21: 
1427.9159; found 1427.9181 [M + Na]
+. 
4. Conclusions  
In  this  paper  we  report  the  isolation  and  the  structural  characterization  of  a  new  swinholide 
congener, swinholide J endowed with potent cytotoxic activity from the marine sponge Theonella 
swinhoei.  The  structure  was  determined  by  extensive  application  of  2D  NMR  techniques.  The 
discovery  of  swinholide  J  reaffirms  the  utility  of  examining  marine  sponge  for  identifying  novel 
potential antitumor lead compounds. Mar. Drugs 2011, 9  
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